Search Tag: gene therapy

Executive Health Management

2020 30 Jul

POSTPONED DUE TO COVID-19 HEALTH CONCERNS FROM APR TO JULY 30-31 Read more

Executive Health Management

2019 26 Aug

Arthur M. Feldman, MD, PhD, Laura H. Carnell Professor of Medicine at the Lewis Katz School of Medicine at Temple University, has been recognised with the 2019 Distinguished Scientist Award-Basic Domain by the American College of Cardiology. Prof. Feldman has received this honour due to his contribution towards improving cardiovascular health and...Read more

Executive Health Management

2019 11 Nov

Find Financial Times Live on Social Media Read more

Cardiology Management

2018 15 May

Following a heart attack, often the heart has difficulty performing one of its most basic jobs: beat at a normal rate. This is because after myocardial infarction, heart muscle cells are replaced by fibroblasts and new blood vessels, which do not conduct electricity and leave the heart susceptible to ventricular tachycardia – an excessive heart...Read more

IMAGING Management

2016 23 Aug

A new study published in the Proceedings of the National Academy of Sciences ( PNAS ) talks about a gene therapy approach called sonoporation which combines ultrasound energy and microbubbles to poke holes in cells. This new tool could help fight against cancer and cardiovascular disease. Researchers from the University of Pittsburgh and UPMC explain...Read more

Cardiology Management

2015 25 May

In a late-breaking trials session at Heart Failure 2015, Dr. Marc Penn, a cardiologist at Summa Cardiovascular Institute in Akron, Ohio, U.S., announced that the gene therapy SDF-1 remodelled the hearts of high risk heart failure patients in the phase II STOP-HF trial. Heart Failure 2015 is the main annual meeting of the Heart Failure Association (HFA) of...Read more

Cardiology Management

2014 03 Dec

Stem cell factor (SCF) delivered directly into damaged heart muscle after a heart attack may help repair and regenerate injured tissue, according to a study by Icahn School of Medicine at Mount Sinai in New York. Researchers administered SCF by gene transfer shortly after inducing heart attacks in pre-clinical models, delivering SCF directly into damaged...Read more